Limited-Stage Small-Cell Lung Cancer With Severe Paraneoplastic Limbic Encephalitis Successfully Treated With Chemoradiotherapy Followed by Immune Checkpoint Inhibitor Maintenance Therapy: A Case Report
Daisuke Morinaga , Hidenori Kitai , Hanko Sato , Doppo Fukui , Wataru Harabayashi , Yukiko Yoshida , Shotaro Ito , Yuta Takashima , Megumi Furuta , Akihiko Kudo , Shintaro Fujii , Hisashi Uwatoko , Hiroaki Yaguchi , Keiko Tanaka , Ichiro Yabe , Jun Sakakibara-Konishi , Satoshi Konno
{"title":"Limited-Stage Small-Cell Lung Cancer With Severe Paraneoplastic Limbic Encephalitis Successfully Treated With Chemoradiotherapy Followed by Immune Checkpoint Inhibitor Maintenance Therapy: A Case Report","authors":"Daisuke Morinaga , Hidenori Kitai , Hanko Sato , Doppo Fukui , Wataru Harabayashi , Yukiko Yoshida , Shotaro Ito , Yuta Takashima , Megumi Furuta , Akihiko Kudo , Shintaro Fujii , Hisashi Uwatoko , Hiroaki Yaguchi , Keiko Tanaka , Ichiro Yabe , Jun Sakakibara-Konishi , Satoshi Konno","doi":"10.1016/j.cllc.2026.01.011","DOIUrl":null,"url":null,"abstract":"<div><div><ul><li><span>•</span><span><div>Tissue-based assays can reveal neuronal antibody reactivity and support the diagnosis of autoimmune or paraneoplastic encephalitis, especially when standard serum and cerebrospinal fluid antibody panels are negative.</div></span></li><li><span>•</span><span><div>In limited-stage small-cell lung cancer with paraneoplastic limbic encephalitis, immune checkpoint inhibitors can be a feasible option when both tumor regression and neurological stabilization are achieved following concurrent chemoradiotherapy.</div></span></li></ul></div></div>","PeriodicalId":10490,"journal":{"name":"Clinical lung cancer","volume":"27 2","pages":"Pages 121-125"},"PeriodicalIF":3.9000,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical lung cancer","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1525730426000252","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/29 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
•
Tissue-based assays can reveal neuronal antibody reactivity and support the diagnosis of autoimmune or paraneoplastic encephalitis, especially when standard serum and cerebrospinal fluid antibody panels are negative.
•
In limited-stage small-cell lung cancer with paraneoplastic limbic encephalitis, immune checkpoint inhibitors can be a feasible option when both tumor regression and neurological stabilization are achieved following concurrent chemoradiotherapy.
期刊介绍:
Clinical Lung Cancer is a peer-reviewed bimonthly journal that publishes original articles describing various aspects of clinical and translational research of lung cancer. Clinical Lung Cancer is devoted to articles on detection, diagnosis, prevention, and treatment of lung cancer. The main emphasis is on recent scientific developments in all areas related to lung cancer. Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; and integration of various approaches.